Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Gabrielle CôtéLori Asselin-ThompstoneFabrice Mac-WayPaul René de CotretChristine LacroixSimon DesmeulesMohsen AgharaziiPublished in: International urology and nephrology (2020)
Both sodium and urea excretion rates contribute significantly to daily urine volume in patients treated with tolvaptan, and a single session of dietary counseling was transiently effective in reducing sodium intake but achieved a more sustained reduction in protein intake. Dietary counseling should be considered in the management of ADPKD patients treated by tolvaptan.
Keyphrases
- polycystic kidney disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- smoking cessation
- physical activity
- weight gain
- prognostic factors
- acute heart failure
- body mass index
- hiv testing
- transcranial direct current stimulation
- weight loss
- protein protein
- amino acid
- hiv infected